Portal de Periódicos da CAPES

Willingness to receive a COVID-19 vaccine in people with multiple sclerosis – UK MS Register survey

2021; Elsevier BV; Volume: 55; Linguagem: Inglês

10.1016/j.msard.2021.103175

2211-0356

Yun Huang, Jeff Rodgers, Rod Middleton, Aravindhan Baheerathan, Katie Tuite-Dalton, David Ford, Richard Nicholas, MS Register Research Group,

Virology and Viral Diseases

Background & Methods: We conducted an online COVID-19 survey as the vaccines became available, utilising the UK MS Register, to understand people with multiple sclerosis (pwMS) views on COVID-19 vaccination and the subsequent vaccine uptake rates.Results & Conclusion: 94.4% of 3191 pwMS surveyed indicated they would get a COVID-19 vaccine, while 5.6% would not. PwMS who have previously had an influenza vaccine, increasing age and the perception of having sufficient information about the vaccine were associated with increased likelihood of getting a vaccine. 51.7% of 3191 pwMS completed a follow-up survey indicating they received at least 1 dose of a COVID-19 vaccine. The proportion having had the vaccination based on their prior opinions was 53.2% in 'Yes' group and 27.0% in 'No' group, the latter reflecting a change based on their initial views. More information on COVID-19 vaccine safety in pwMS would be helpful for people to make informed decisions.